RISVAN FDA approval date

The FDA approved RISVAN on 29 Mar 2024.

FDA approval date
29 Mar 2024

Drug identity has not yet been verified against registry records

Also recorded as RISPERIDONE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2024-03-29DayRISVANFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA214835", "applicant_as_listed_by_fda": "LABS FARMS ROVI SA", "brand_names": ["RISVAN"], "active_ingredients": ["RISPERIDONE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20240329", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026